Cancer remains the most devastating disease and the major cause of mortality worldwide.
Although early diagnosis and treatment are the key approach in fighting against cancer, the …

Neurodegenerative diseases (NDD) are progressive degenerative disorders of the
neurological system with significant social impact worldwide. Their detection at the initial …

Glioblastoma (GBM) is a fatal and recurrent brain cancer without any complete prevailing
remedy. Here, we explored single-atom nanozyme-mediated catalytic therapy to precisely …

The effective treatment of glioblastoma (GBM) is a great challenge because of the blood-
brain barrier (BBB) and the growing resistance to single-agent therapeutics. Targeted …

Defect engineering is an emerging technology for tailoring nanomaterials' characteristics
and catalytic performance in various applications. Recently, defect‐engineered …

Alzheimer's disease (AD) is the most common neurological disease and a serious cause of
dementia, which constitutes a threat to human health. The clinical evidence has found that …

Glioblastoma (GBM) as the most common primary malignant brain tumor exhibits a high
incidence and degree of malignancy as well as poor prognosis. Due to the existence of …

The treatment of central nervous system (CNS) malignancies, including brain cancers, is
limited by a number of obstructions, including the blood-brain barrier (BBB), the …

Various types of inorganic nanomaterials are capable of diagnostic biomarker detection and
the therapeutic delivery of a disease or inflammatory modulating agent. Those multi …

Neurodegenerative disorders represent a significant and growing global health challenge,
necessitating continuous advancements in diagnostic tools for accurate and early detection …